Bausch Health Beats Suit Over 'Faking' Financial Stability

By Katryna Perera · February 12, 2025, 10:15 PM EST

Pharmaceutical company Bausch Health Cos. Inc. and its top brass have beaten, for now, a proposed class action accusing them of misleading shareholders about threats to the company's financial stability, with...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

KELK v. BAUSCH HEALTH COMPANIES INC. et al

Case Number

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

July 26, 2023

Recent Articles By Katryna

February 14, 2025
Digital Health Co. Beats Some Claims In SPAC Investor Suit
February 11, 2025
Labaton Keller Appointed Lead In Healthcare Co. IPO Suit
February 11, 2025
Research Org Faces Investor Suit Over Customer Cost-Cutting
February 06, 2025
GSK's Zantac Woes Gave Investors Heartburn, Suit Says
February 04, 2025
Judge Explains Biogen Class Cert. Ruling After 1st Circ. Order
January 10, 2025
9th Circ. Affirms Hearing Aid Co.'s Win Over Investor Suit
January 09, 2025
CFPB Hit With 2nd Suit Over Medical Debt Reporting Rule
December 05, 2024
FINRA Fines Firm $900K Over SPAC Underwriting Fee Issues
November 04, 2024
Late New Evidence Can't Revive Investor Suit, Judge Says
October 31, 2024
Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand